TCG CROSSOVER MANAGEMENT, LLC
Latest 13F filing data - Q4 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
 | TNGX | 12.76M | $113.07M |
 | SVRA | 12.36M | $74.54M |
 | ADCT | 11.39M | $40.21M |
 | ALEC | 10.00M | $15.60M |
 | ABVX | 7.11M | $959.03M |
 | AMLX | 6.24M | $75.43M |
 | COGT | 5.87M | $208.44M |
 | OCUL | 5.74M | $69.69M |
 | FULC | 5.25M | $59.38M |
 | BHVN | 4.63M | $52.29M |
 | GLUE | 4.62M | $72.48M |
 | DYN | 4.62M | $90.27M |
 | CNTA | 4.29M | $107.20M |
 | CGON | 3.67M | $152.39M |
 | EYPT | 3.57M | $65.27M |
 | RLAY | 3.22M | $27.24M |
 | SLN | 3.03M | $18.44M |
 | TYRA | 2.90M | $76.19M |
 | VTGN | 2.68M | $1.77M |
 | ARVN | 2.67M | $31.62M |
Tango Therapeutics, Inc.
TNGX
Shares Held
12.76M
Value
$113.07M
Savara Inc.
SVRA
Shares Held
12.36M
Value
$74.54M
ADC Therapeutics S.A.
ADCT
Shares Held
11.39M
Value
$40.21M
Alector, Inc.
ALEC
Shares Held
10.00M
Value
$15.60M
Abivax S.A.
ABVX
Shares Held
7.11M
Value
$959.03M
Amylyx Pharmaceuticals, Inc.
AMLX
Shares Held
6.24M
Value
$75.43M
Cogent Biosciences, Inc.
COGT
Shares Held
5.87M
Value
$208.44M
Ocular Therapeutix, Inc.
OCUL
Shares Held
5.74M
Value
$69.69M
Fulcrum Therapeutics, Inc.
FULC
Shares Held
5.25M
Value
$59.38M
Biohaven Ltd.
BHVN
Shares Held
4.63M
Value
$52.29M
Monte Rosa Therapeutics, Inc.
GLUE
Shares Held
4.62M
Value
$72.48M
Dyne Therapeutics, Inc.
DYN
Shares Held
4.62M
Value
$90.27M
Centessa Pharmaceuticals plc
CNTA
Shares Held
4.29M
Value
$107.20M
CG Oncology, Inc. Common stock
CGON
Shares Held
3.67M
Value
$152.39M
EyePoint Pharmaceuticals, Inc.
EYPT
Shares Held
3.57M
Value
$65.27M
Relay Therapeutics, Inc.
RLAY
Shares Held
3.22M
Value
$27.24M
Silence Therapeutics plc
SLN
Shares Held
3.03M
Value
$18.44M
Tyra Biosciences, Inc.
TYRA
Shares Held
2.90M
Value
$76.19M
VistaGen Therapeutics, Inc.
VTGN
Shares Held
2.68M
Value
$1.77M
Arvinas, Inc.
ARVN
Shares Held
2.67M
Value
$31.62M